Founded on the belief that success means nothing unless you’re giving back, Francesca Jewellery combines beautiful design with an empowering purpose.
Francesca is supporting Bowel Cancer Australia for its fourth year with their Awareness Bracelet campaign. $20 from every bracelet purchased is donated to support those affected by bowel cancer.

Grampians Health is delighted to welcome a new dedicated Bowel Care Nurse, a position funded by Bowel Cancer Australia to provide tailored support to bowel cancer patients across the region.

Jaymee Goldsmith, a registered nurse who has specialist knowledge and experience caring for patients with bowel cancer, will be working two days a week at Ballarat Base Hospital and St John of God Hospital Ballarat to support bowel cancer patients across the Grampians region and assist them in their treatment journey.

Bowel Cancer Australia launched the final instalment of its bold 'Give a $#*! About Your Bowel' advertising campaign featuring acclaimed actress Miriam Margolyes OBE in the lead up to Bowel Cancer Awareness Month 2023.
The third instalment of this high impact series focuses on 'cancer' with a clear message that when caught early almost 99% of bowel cancer cases can be successfully treated.

Bowel Cancer Australia Medical Director and recently retired colorectal surgeon, A/Prof Graham Newstead AM was recently made an Honorary Fellow of the American College of Surgeons (ACS).
The award was accompanied by the citation: “The American College of Surgeons pays tribute to your outstanding achievements in surgery, your international reputation, and your distinguished humanitarian services”.

The latest AIHW National Bowel Cancer Screening Program (NBCSP) Report (2019-2020) reveals participation rates continue to remain static at 43.8% (2018-19: 43.5%) and colonoscopy wait times for those who receive a positive screen continue to exceed the recommended 30 days.

According to the report, 5.76 million people aged 50-74 were invited to participate in the NBCSP in 2019-20 and 2.52 million tests were returned.

Biomarker testing identifies the unique mutations in your tumour, helping your medical team develop a treatment plan that is tailored to you, more efficient, and less likely to provide unnecessary side effects.
Dying tumour cells release small pieces of their DNA into the bloodstream. These pieces are called circulating tumour DNA (ctDNA).

Anal cancer is considered a rare disease, with 514 people diagnosed and 129 deaths each year in Australia.

The anus (back passage) is the 4 cm long end portion of the large bowel, which opens to allow poo to exit the body. The anus is formed partly from the outer skin layers of the body and partly from the intestine. Two ring-like muscles, called sphincter muscles, open and close the anal opening and let poo pass out of the body.

Bowel cancer is the third most common cancer in Australia.
Around 69% of bowel cancers are located in the colon and 31% in the rectum.
Each year there are 4,919 new rectal cancer cases and 2,815 rectal cancer deaths.

Bowel Cancer Australia recommends participating in screening appropriate to your personal level of risk.
The decision to be screened for people over the age of 75 should be based on an individual’s preferences, life expectancy, overall health, and prior screening history.
People aged 75 and over are not eligible to participate in the National Bowel Cancer Screening Program (NBCSP).